a flexible approach to phase ii-iv clinical services€¦ · a flexible approach to phase ii-iv...
TRANSCRIPT
A flexible approach to
Phase II-IVClinicalServices
QPS IS A GLOBAL CRO WITH DIVERSE CAPABILITES THAT OFFERS END TO END
SERIVCES TO PHARMA AND BIOPHARMA COMPANIES enabling them to bring products to
market in a faster and more compliant manner. With operations in India, USA, Europe and Taiwan, QPS is ideally positioned to address the key global
generic product development requirements of quality, compliance, and time to market.
TIME IS OF THE ESSENCE IN DRUG DEVELOPMENT.CONTACT THE QPS BUSINESS DEVELOPMENT TEAM TODAY!
CALL +1 512 350 2827 EMAIL [email protected]
www.qps.com | [email protected] | +1 512-350-2827
Services Offered • Biostatistics • Data Management • Medical Writing • Monitoring • Pharmacogenomics (RNA/DNA) Pharmacovigilance • PK/PD evaluation • Program, Project and Study Management Regulatory Affairs
Therapeutic Area Focus • CNS - including Parkinson's Disease and Alzheimer's Disease • Endocrinology - including Diabetes and Obesity • Oncology • Pulmonary/Respiratory - including Asthma, Emphysema and COPD • Dermatology - Dermal and Transdermal delivery systems • Vaccines - Flu, RSV, Hepatitis, HPV, Ebola, Zika, and others!
Why Choose Qps For Phase II-IV Services? • Boutique style CRO providing the highest level of customized service. • Global footprint with 11 locations in Asia, Europe and North America. • Low turn-over of staff • Monitoring efficiency increased by strategic site and study support • Access to a large network of investigators across therapeutic areas • Experienced personnel with medical, regulatory and cultural knowledge • Direct access to scientists
The Global Footprint Of QPS
QPS India:
• Extensive experience with generic and biosimilar studies• Fast recruitment of patients
QPS Missouri
• All 5 units available for Phase II-IV trials• PI Experience: Family Practice, Skin Cancer & Hepatitis CSpecialists, Ophthalmology
QPS Netherlands
• Capable of monitoring studies in several countries(Belgium, Northern Germany, NL, UK)• Cardiology studies are well promoted in NL, with goodrecruitment rates
QPS Taiwan
• Fast governmental regulatory approval to start studies• Clinical Research Coordinators with UNITIX, an SMO, canincrease study efficiency
QPS Austria
• Clinical studies have involved over 15,000 subjects• In-depth knowledge and understanding of European andlocal regulations
QPS Miami
• Over 1,200 clinical trials conducted across Phase 1, Late Phaseand Vaccines• A robust database of 30,000 subjects/patients
FLEXIBILITY. AGILITY. SPEED.
WWW.QPS.COM
CALL +1 512 350 2827EMAIL [email protected]
QPS is a Global CROwith locations around the world
to serve the evolving needs of the Pharmaceutical and Biotech industries
Phase II - IVClinical Services
Fargo, ND, USADermal and Transdermal
Research Laboratory (DTRL)
Groningen and Leeuwarden, The Netherlands
Bioanalysis (BA)Clinical Research Services (CRS)
Translational Medicine (TLM)
Suzhou and Shanghai,China
BioanalysisClinical Research Services (CRS)
Miami, FL, USAClinical Research
Services (CRS)
Hyderabad, IndiaClinical Research
Services (CRS)
Taipei, TaiwanBioanalysis (BA)
Clinical Research Services (CRS)Toxicology (TOX)
Translational Medicine (TLM)
Newark, DE, USABioanalysis (BA)
Clinical Research Services (CRS)DMPK
Translational Medicine (TLM)Global Headquarters for
QPS Holdings LLC
Graz, AustriaClinical Research Services (CRS)
DMPKHistology Services
NeuropharmacologyOrphan/Rare Disease
Rodent Biobank
Springfield, MO, USAClinical Research
Services (CRS)